Nanotechnology-assisted thermal ablation for hepatocellular carcinoma: Focus on radiofrequency and microwave ablation
Biochemical and Biophysical Research Communications · 2026-09 · 831 · 154269
DOI: 10.1016/j.bbrc.2026.154269 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-09. Verfasst von Changzheng Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, 1300…. Hauptthemen laut MEDLINE: Liver Neoplasms, Ablation Techniques, Nanotechnology. Die Arbeit nennt 162 Literaturangaben. Gefördert von: Jilin Provincial Science and Technology Department, Jilin Provincial Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND Hepatocellular carcinoma (HCC) remains a major cause of cancer-related mortality. Radiofrequency ablation (RFA) and microwave ablation (MWA) are established local therapies for early-stage and selected intermediate-stage HCC, but their efficacy is limited by heat-sink-related underheating, uncertain margin delineation, and post-ablation microenvironmental remodeling that favors residual disease and recurrence. METHODS This review summarizes nanotechnology-assisted strategies designed to improve RFA/MWA for HCC. We focus on nanoplatforms that enhance energy deposition, support image-guided margin assessment, and modulate post-ablation immune and metabolic responses, while critically appraising clinical feasibility, safety, and translational barriers. RESULTS Nanomaterials can improve thermal sensitization by increasing local energy absorption, heat retention, cavitation, vascular occlusion, or microwave coupling, thereby reducing incomplete ablation. Imaging-enabled platforms based on magnetic resonance, computed tomography, ultrasound, fluorescence, or positron emission tomography can help identify residual viable tumor and define ablation margins. Immunomodulatory platforms further amplify immunogenic cell death, antigen capture, stimulator of interferon genes (STING) signaling, checkpoint blockade, myeloid reprogramming, metabolic remodeling, and epithelial-mesenchymal transition suppression, potentially converting transient local inflammation into more durable antitumor immunity. CONCLUSIONS Nanotechnology should be viewed as a functional enhancer of RFA/MWA rather than an independent ablation modality. Translation requires procedure-compatible and image-guided delivery, integration with transarterial chemoembolization or immunotherapy, biomarker-based patient selection, standardized margin-assessment endpoints, recurrence-free survival outcomes, and rigorous safety/manufacturing evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130021, China.
- Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130021, China. Electronic address: ji_bai@jlu.edu.cn.
Förderung
- Jilin Provincial Science and Technology Department
- Jilin Provincial Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Li, C., Ke, J., Li, X., & Ji, B. (2026). Nanotechnology-assisted thermal ablation for hepatocellular carcinoma: Focus on radiofrequency and microwave ablation. Biochemical and Biophysical Research Communications, 831, 154269. https://doi.org/10.1016/j.bbrc.2026.154269
Vancouver
Li C, Ke J, Li X, Ji B. Nanotechnology-assisted thermal ablation for hepatocellular carcinoma: Focus on radiofrequency and microwave ablation. Biochemical and Biophysical Research Communications. 2026;831:154269. doi:10.1016/j.bbrc.2026.154269
BibTeX
@article{Li2026,
author = {Li, Changzheng and Ke, Jianji and Li, Xiaocheng and Ji, Bai},
title = {Nanotechnology-assisted thermal ablation for hepatocellular carcinoma: Focus on radiofrequency and microwave ablation},
journal = {Biochemical and Biophysical Research Communications},
year = {2026},
volume = {831},
pages = {154269},
doi = {10.1016/j.bbrc.2026.154269}
}
EUVIMED